Novavax receives positive opinion from CHMP for full MA of Covid vaccine
Pharmaceutical Technology
MAY 29, 2023
Novavax has received positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for full marketing authorisation (MA) of its Covid vaccine, Nuvaxovid (NVX-CoV2373) , in the European Union (EU). The safety and efficacy of Nuvaxovid was evaluated as a primary series.
Let's personalize your content